746598-41-4

Upstream product

• 312638-87-2 4-cyclohexyl-4-hydroxymethylpiperidine-1-carboxylic acid tert-butyl ester 
• 363192-22-7 4-cyclohexyl-4-formyl-piperidine-1-carboxylic acid tert-butyl ester 
• 401843-91-2 {1-(4-chloro-benzyl)-2-[4-cyclohexyl-4-(4,4-dimethyl-2-oxo-oxazolidin-3-ylmethyl)-piperidin-1-yl]-2-oxo-ethyl}-carbamic acid tert-butyl ester 
• 363192-34-1 1-BOC-4-cyclohexyl-4-[(4,4-dimethyloxazolidin-2-one-3-yl)methyl]piperidine 
• 363192-33-0 4-cyclohexyl-4-[(2-hydroxy-1,1-dimethyl-ethylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands

Design and synthesis of potent MC4 selective agonists based on cyclohexylpiperidine derived cyclic urea, oxazolidinones, and sulfonamide based privileged structures are disclosed.